"The possibility that a patent can cut off a 15-year-old generic market on a half-century-old drug and raise prices by nearly 24,000% is an alarming development at a time that healthcare costs are already skyrocketing." lat.ms/3RfZr2U Michael Carrier Charles Duan

This is starting soon! Looking forward to talking with Abby Rives Engine to talk about startups, patent policy, and public interest careers

Join us on October 6th at 12:00 pm for a virtual conversation with Alex Moss about the big issues in patent policy conversations today. Hosted by Charles Duan. The speaker has changed this week, and the virtual conversation with Zain Rizvi will be on November 2nd at 12:00 pm.

This is starting in a few minutes! Looking forward to talking with alex about how to start a patent policy nonprofit, Public Interest Patent Law Institute!

In less than a month, Princeton University Press will publish “You Are Not Expected to Understand This.” If you’re in DC, join us Nov. 15 for a happy hour event with contributors @EllenStofan, Will Oremus, Charles Duan, & Lemelson Center’s Arthur Daemmrich newamerica.org/future-tense/e…

This is happening right now--join us for a conversation with Joe Mullin at EFF on patents and the public interest!

This is happening in less than an hour!

Charles Duan will join American University as Assistant Professor with a teaching and research interest in Patent Law. Duan is currently a postdoctoral fellow at Cornell Tech, and serves as a member of the Patent Public Advisory Committee of the USPTO. tinyurl.com/CharlesDuanAUW…

Really delighted and excited about this!

Congratulations S. Sean Tu!

I've been consistently impressed with USPTO Director Vidal's dedication and openness to engagement with all stakeholders. A real honor to serve on PPAC with her leadership